Table 2.
Physical and biochemical parameters of cardiovascular diseases among the study population, n = 265.
| Parameters | Mean ± SD | Median (IQR) | n (%) |
|---|---|---|---|
| BMI (kg/m2) | 23.26 ± 4.74 | 23.05 (20.13–26.02) | |
| Nonobese | 245 (92.5) | ||
| Generalized obese (≥30 kg/m2) | 20 (7.5) | ||
| WHR | 0.89 ± 0.07 | 0.89 (0.85–0.94) | |
| Nonobese | 71 (26.8) | ||
| Centrally obese (>0.85) | 194 (73.2) | ||
| SBP (mmHg) | 120.56 ± 20.17 | 120 (100–140) | |
| Normal to prehypertension | 189 (71.3) | ||
| Hypertension (≥140 mmHg) | 76 (28.7) | ||
| DBP (mmHg) | 76.72 ± 11.49 | 80 (70–85) | |
| Normal to prehypertension | 189 (71.3) | ||
| Hypertension (≥90 mmHg) | 57 (21.5) | ||
| FPG (mmol/l) | 5.91 ± 2.39 | 5 (5–6) | |
| Nondiabetic | 217 (81.9) | ||
| Diabetic (≥7.0 mmol/l) | 48 (18.1) | ||
| 2-h PG (mmol/l), n = 223 | 6.24 ± 1.97 | 6 (5–7) | |
| Nondiabetic | 215 (96.4) | ||
| Diabetic (≥11.0 mmol/l) | 8 (3.6) | ||
| TC (mmol/l) | 5.23 ± 1.3 | 5.12 (4.36–6.19) | |
| Desirable to borderline high | 197 (74.3) | ||
| Hypercholesterolemia (≥6.2 mmol/l) | 68 (25.7) | ||
| HDL-C (mmol/l) | 1.1 ± 0.3 | 1 (1–1) | |
| Low (<1.0 mmol/l) | 70 (26.4) | ||
| High | 195 (73.6) | ||
| LDL-C (mmol/l) | 3.19 ± 1.18 | 3 (2–4) | |
| Optimal to borderline high | 210 (79.2) | ||
| High (>4.1 mmol/l) | 55 (20.8) | ||
| TG (mmol/l) | 1.86 ± 1.13 | 2 (1–2) | |
| Normal to borderline high | 153 (57.7) | ||
| High (>2.3 mmol/l) | 112 (52.3) | ||
| AIP | 0.16 ± 0.25 | 0.13 (−0.03 to 0.32) | |
| Low risk (<0.11) | 124 (47.3) | ||
| Intermediate risk (0.11–0.24) | 45 (17.2) | ||
| High risk (>0.24) | 93 (35.5) |
SD, standard deviation; IQR, interquartile range; BMI, body mass index; WHR, waist–hip ratio; SBP, systolic blood pressure, DBP, diastolic blood pressure; FPG, fasting plasma glucose; 2-h PG, 2-h plasma glucose; TC, total cholesterol; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; TG, triglyceride; AIP, atherogenic index of plasma.